Automate Your Wheel Strategy on IQV
With Tiblio's Option Bot, you can configure your own wheel strategy including IQV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IQV
- Rev/Share 93.443
- Book/Share 36.9448
- PB 5.8865
- Debt/Equity 2.4659
- CurrentRatio 0.7028
- ROIC 0.0787
- MktCap 36281053397.0
- FreeCF/Share 15.5112
- PFCF 13.7428
- PE 28.2628
- Debt/Assets 0.5288
- DivYield 0
- ROE 0.214
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | IQV | TD Cowen | Buy | Hold | -- | $215 | Nov. 3, 2025 |
| Upgrade | IQV | Robert W. Baird | Neutral | Outperform | -- | $258 | Oct. 29, 2025 |
| Upgrade | IQV | HSBC Securities | Hold | Buy | -- | $235 | Oct. 9, 2025 |
| Upgrade | IQV | Jefferies | Hold | Buy | -- | $225 | Sept. 9, 2025 |
| Downgrade | IQV | HSBC Securities | Buy | Hold | -- | $160 | April 25, 2025 |
| Downgrade | IQV | Barclays | Overweight | Equal Weight | -- | $170 | April 10, 2025 |
| Downgrade | IQV | BTIG Research | Buy | Neutral | -- | -- | Feb. 3, 2025 |
| Initiation | IQV | Stephens | -- | Overweight | -- | $250 | Dec. 20, 2024 |
| Initiation | IQV | Redburn Atlantic | -- | Buy | -- | -- | Oct. 14, 2024 |
News
IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of IQVIA (IQV) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
IQVIA (IQV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Here's Why Investors Must Hold IQV Stock in Their Portfolios Now
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The IQV stock is benefiting from partner retention, acquisition and investment in AI-led innovation.
Read More
IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The IQV stock benefits from its healthcare-centric IT infrastructure across the globe and a treasure trove of data distinguishing it from its competitors.
Read More
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.
Read More
About IQVIA Holdings Inc. (IQV)
- IPO Date 2013-05-09
- Website https://www.iqvia.com
- Industry Medical - Diagnostics & Research
- CEO Ari Bousbib
- Employees 89000